Conference abstract
Screening and prevention of cervical cancer in Dschang Health District, Cameroon: a glance on the first three years´ achievement of the “3T project”
Pan African Medical Journal - Conference Proceedings. 2023:17(28).04
Jun 2023.
doi: 10.11604/pamj-cp.2023.17.28.1675
Archived on: 04 Jun 2023
Contact the corresponding author
Keywords: Cervical cancer screening, precancerous lesions treatment, Dschang, Cameroon
Oral presentation
Screening and prevention of cervical cancer in Dschang Health District, Cameroon: a glance on the first three years´ achievement of the “3T project”
Kenfack Bruno1,2,&, Sormani J3, Fouogue Tsuala J1,4, Noubom M2, Tankeu Happi G2, Datchoua Moukan AM2, Lemoupa S4, Vassilakos P5, Petignat P3
1Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Cameroon, 2Dschang District hospital, West Region, Cameroon, 3Division of Gynecology, Department of Gynecology and Obstetrics, Geneva University Hospitals, Geneva, Switzerland, 4Bafoussam Regional hospital, Cameroon, 5Geneva Foundation for Medical Education and Research, Geneva, Switzerland
&Corresponding author
Introduction: cervical cancer is the second leading gynaecological cancer worldwide, occurring mostly in low- and middle-income (LMIC) countries. However, when diagnosed early, cervical cancer is one of the most treatable forms of cancer. The”3T (test, triage and treat) project” in Dschang aims to screen women using HPV test, do a triage for HPV positive to select eligible cases and treat.
Methods: this is an ongoing 5-years prospective cohort study in the Dschang Health District Cameroon, targeting women aged between 30 and 49 years. Data presented concern the first 2623 women screened from September 2018 to August 2021. The SecuTrial platform was used to enter data. The analyzes were done using descriptive methods. The main indicators were the prevalence of HPV infection, the prevalence of precancerous lesions, the treatment options used, and side effects.
Results: out of the 2623 women screened, 482 were HPV-positive (18.4%), with 45 (9.3%) positive for HPV 16, 71 (14.7%) positive for HPV18/45, and 397 (82.4%) positive for other high-risk HPV. Triage done using visual inspection with acetic acid (VIA) was positive for 273/482 women (56.7%) who were subsequently treated. Thermal ablation was the main treatment method used: 264 cases (96.7%), followed by Large Loop Excision of transformation Zone (LLETZ) 9 cases (3.3%). The most common side effect of treatment was watery discharge (77.8%).
Conclusion: HPV infection is relatively common in the Dschang Health District. Screen-triage-and-treat strategy is feasible, and treatment side effects are minor.
Screening and prevention of cervical cancer in Dschang Health District, Cameroon: a glance on the first three years´ achievement of the “3T project”
Kenfack Bruno1,2,&, Sormani J3, Fouogue Tsuala J1,4, Noubom M2, Tankeu Happi G2, Datchoua Moukan AM2, Lemoupa S4, Vassilakos P5, Petignat P3
1Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Cameroon, 2Dschang District hospital, West Region, Cameroon, 3Division of Gynecology, Department of Gynecology and Obstetrics, Geneva University Hospitals, Geneva, Switzerland, 4Bafoussam Regional hospital, Cameroon, 5Geneva Foundation for Medical Education and Research, Geneva, Switzerland
&Corresponding author
Introduction: cervical cancer is the second leading gynaecological cancer worldwide, occurring mostly in low- and middle-income (LMIC) countries. However, when diagnosed early, cervical cancer is one of the most treatable forms of cancer. The”3T (test, triage and treat) project” in Dschang aims to screen women using HPV test, do a triage for HPV positive to select eligible cases and treat.
Methods: this is an ongoing 5-years prospective cohort study in the Dschang Health District Cameroon, targeting women aged between 30 and 49 years. Data presented concern the first 2623 women screened from September 2018 to August 2021. The SecuTrial platform was used to enter data. The analyzes were done using descriptive methods. The main indicators were the prevalence of HPV infection, the prevalence of precancerous lesions, the treatment options used, and side effects.
Results: out of the 2623 women screened, 482 were HPV-positive (18.4%), with 45 (9.3%) positive for HPV 16, 71 (14.7%) positive for HPV18/45, and 397 (82.4%) positive for other high-risk HPV. Triage done using visual inspection with acetic acid (VIA) was positive for 273/482 women (56.7%) who were subsequently treated. Thermal ablation was the main treatment method used: 264 cases (96.7%), followed by Large Loop Excision of transformation Zone (LLETZ) 9 cases (3.3%). The most common side effect of treatment was watery discharge (77.8%).
Conclusion: HPV infection is relatively common in the Dschang Health District. Screen-triage-and-treat strategy is feasible, and treatment side effects are minor.
